Literature DB >> 16645549

Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users.

Peter Vickerman1, Matthew Hickman, Tim Rhodes, Charlotte Watts.   

Abstract

BACKGROUND: Although syringe distribution is effective in preventing HIV transmission among injecting drug users (IDUs), there is little evidence on the required coverage to substantially reduce HIV transmission.
METHODS: A mathematical model is developed to explore the relationship between the endemic HIV prevalence among IDUs and the coverage of syringe distribution. Data from IDU populations in the United Kingdom and Belarus are used to explore the implications of increasing coverage and the effect of changes in other behaviors.
RESULTS: Projections suggest that there is a coverage threshold, which, if reached, could lead to substantial decreases in HIV prevalence. The threshold largely depends on the frequency that IDUs inject and (safely) reuse their syringes, and corresponds to less than 4 syringe-sharing events per IDU per month. Other factors, such as the injecting cessation rate and efficacy of syringe cleaning, only have substantial impact near threshold coverage levels.
CONCLUSIONS: Our results support a policy of increasing the coverage of syringe distribution but highlight the difficulty in producing a universal coverage target. Great public health benefit could be conferred by encouraging the safe reuse of an IDU's own syringes and small stable injecting groups. Policies that discourage this will negate the impact of syringe distribution interventions.

Mesh:

Year:  2006        PMID: 16645549     DOI: 10.1097/01.qai.0000219788.73539.47

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  17 in total

1.  Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.

Authors:  Barbara Tempalski; Hannah L Cooper; Samuel R Friedman; Don C Des Jarlais; Joanne Brady; Karla Gostnell
Journal:  Int J Drug Policy       Date:  2008-03-04

Review 2.  Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward.

Authors:  Mukta Sharma; Dave Burrows; Ricky Bluthenthal
Journal:  Int J Drug Policy       Date:  2007-01-02

3.  Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange.

Authors:  Robert Heimer
Journal:  Int J Drug Policy       Date:  2008-01-18

4.  Implementation science for the prevention and treatment of HIV/AIDS.

Authors:  Bruce R Schackman
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

5.  Do metropolitan HIV epidemic histories and programs for people who inject drugs and men who have sex with men predict AIDS incidence and mortality among heterosexuals?

Authors:  Samuel R Friedman; Brooke S West; Barbara Tempalski; Cory M Morton; Charles M Cleland; Don C Des Jarlais; H Irene Hall; Hannah L F Cooper
Journal:  Ann Epidemiol       Date:  2014-01-24       Impact factor: 3.797

6.  Syringe exchange in the United States: a national level economic evaluation of hypothetical increases in investment.

Authors:  Trang Quynh Nguyen; Brian W Weir; Don C Des Jarlais; Steven D Pinkerton; David R Holtgrave
Journal:  AIDS Behav       Date:  2014-11

7.  Identifying heterogeneity among injection drug users: a cluster analysis approach.

Authors:  Souradet Y Shaw; Lena Shah; Ann M Jolly; John L Wylie
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

8.  Syringe Coverage Among People Who Inject Drugs in West Virginia, USA.

Authors:  Sean T Allen; Rebecca Hamilton White; Allison O'Rourke; Kristin E Schneider; Brian W Weir; Gregory M Lucas; Michael E Kilkenny; Susan G Sherman
Journal:  AIDS Behav       Date:  2021-04-22

9.  HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy.

Authors:  Emma Jolley; Tim Rhodes; Lucy Platt; Vivian Hope; Alisher Latypov; Martin Donoghoe; David Wilson
Journal:  BMJ Open       Date:  2012-10-18       Impact factor: 2.692

Review 10.  High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review.

Authors:  Don C Des Jarlais; Jonathan P Feelemyer; Shilpa N Modi; Abu Abdul-Quader; Holly Hagan
Journal:  BMC Public Health       Date:  2013-01-19       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.